BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schloer S, Hübel N, Masemann D, Pajonczyk D, Brunotte L, Ehrhardt C, Brandenburg LO, Ludwig S, Gerke V, Rescher U. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model. FASEB J 2019;33:12188-99. [PMID: 31398292 DOI: 10.1096/fj.201901265R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Grewal T, Rentero C, Enrich C, Wahba M, Raabe CA, Rescher U. Annexin Animal Models-From Fundamental Principles to Translational Research. Int J Mol Sci 2021;22:3439. [PMID: 33810523 DOI: 10.3390/ijms22073439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Xin Y, Chen S, Tang K, Wu Y, Guo Y. Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion. Int J Mol Sci 2022;23:2372. [PMID: 35216485 DOI: 10.3390/ijms23042372] [Reference Citation Analysis]
3 Filina Y, Gabdoulkhakova A, Rizvanov A, Safronova V. MAP kinases in regulation of NOX activity stimulated through two types of formyl peptide receptors in murine bone marrow granulocytes. Cell Signal 2022;90:110205. [PMID: 34826588 DOI: 10.1016/j.cellsig.2021.110205] [Reference Citation Analysis]
4 Ma X, Zhang K, Luo Z, Nian X, Choudhury SKM, Zhu Z, Song R, Pei J, Huo Y, Li Y, Yang F, Cao W, Liu H, Liu X, Zheng H. FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication. J Virol 2022;:e0031722. [PMID: 35604142 DOI: 10.1128/jvi.00317-22] [Reference Citation Analysis]
5 Gröper J, König GM, Kostenis E, Gerke V, Raabe CA, Rescher U. Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing. Cells 2020;9:E1054. [PMID: 32340221 DOI: 10.3390/cells9041054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Jin K, Gao S, Yang P, Guo R, Li D, Zhang Y, Lu X, Fan G, Fan X. Single-Cell RNA Sequencing Reveals the Temporal Diversity and Dynamics of Cardiac Immunity after Myocardial Infarction. Small Methods 2022;:e2100752. [PMID: 35023642 DOI: 10.1002/smtd.202100752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Holthenrich A, Terglane J, Naß J, Mietkowska M, Kerkhoff E, Gerke V. Spire1 and Myosin Vc promote Ca2+-evoked externalization of von Willebrand factor in endothelial cells. Cell Mol Life Sci 2022;79:96. [PMID: 35084586 DOI: 10.1007/s00018-021-04108-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Trojan E, Bryniarska N, Leśkiewicz M, Regulska M, Chamera K, Szuster-Głuszczak M, Leopoldo M, Lacivita E, Basta-Kaim A. The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology. Curr Neuropharmacol 2020;18:229-49. [PMID: 31629396 DOI: 10.2174/1570159X17666191019170244] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
9 Land WG. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia. Genes Immun 2021;22:141-60. [PMID: 34140652 DOI: 10.1038/s41435-021-00140-w] [Reference Citation Analysis]
10 Vastrad B, Vastrad C, Tengli A. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19. Gene Rep 2020;21:100956. [PMID: 33553808 DOI: 10.1016/j.genrep.2020.100956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Puchkova LV, Kiseleva IV, Polishchuk EV, Broggini M, Ilyechova EY. The Crossroads between Host Copper Metabolism and Influenza Infection. Int J Mol Sci 2021;22:5498. [PMID: 34071094 DOI: 10.3390/ijms22115498] [Reference Citation Analysis]
12 Rüger M, Kipp E, Schubert N, Schröder N, Pufe T, Stope MB, Kipp M, Blume C, Tauber SC, Brandenburg LO. The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis. J Neuroinflammation 2020;17:325. [PMID: 33121515 DOI: 10.1186/s12974-020-02006-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Luo J, Wang S, Zhou Z, Zhao Y. Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia/reperfusion injuries. Mol Ther Methods Clin Dev 2021;20:551-8. [PMID: 33665225 DOI: 10.1016/j.omtm.2021.01.012] [Reference Citation Analysis]
14 Trojan E, Tylek K, Leśkiewicz M, Lasoń W, Brandenburg LO, Leopoldo M, Lacivita E, Basta-Kaim A. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures. Cells 2021;10:1524. [PMID: 34204273 DOI: 10.3390/cells10061524] [Reference Citation Analysis]
15 Xu J, Yu C, Luo J, Guo Y, Cheng C, Zhang H. The role and mechanism of the annexin A1 peptide Ac2-26 in rats with cardiopulmonary bypass lung injury. Basic Clin Pharmacol Toxicol 2021;128:719-30. [PMID: 33455036 DOI: 10.1111/bcpt.13561] [Reference Citation Analysis]
16 Lucchi DBM, Sasso GRS, Sena LS, Franco PC, Lice I, Borges FT, Oliani SM, Gil CD. Protective effects of annexin A1-derived peptide Ac2-26 on liver and kidney injuries induced by cisplatin in rats. Life Sci 2022;:120677. [PMID: 35654117 DOI: 10.1016/j.lfs.2022.120677] [Reference Citation Analysis]
17 Qi F, Liu M, Li F, Lv Q, Wang G, Gong S, Wang S, Xu Y, Bao L, Qin C. Interleukin-37 Ameliorates Influenza Pneumonia by Attenuating Macrophage Cytokine Production in a MAPK-Dependent Manner. Front Microbiol 2019;10:2482. [PMID: 31736917 DOI: 10.3389/fmicb.2019.02482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
18 Tavares LP, Peh HY, Tan WSD, Pahima H, Maffia P, Tiligada E, Levi-Schaffer F. Granulocyte-targeted therapies for airway diseases. Pharmacol Res 2020;157:104881. [PMID: 32380052 DOI: 10.1016/j.phrs.2020.104881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
19 Ahmed F, Kleffmann T, Husain M. Acetylation, Methylation and Allysine Modification Profile of Viral and Host Proteins during Influenza A Virus Infection. Viruses 2021;13:1415. [PMID: 34372620 DOI: 10.3390/v13071415] [Reference Citation Analysis]
20 Sousa LP, Pinho V, Teixeira MM. Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19? Br J Pharmacol 2020;177:3898-904. [PMID: 32557557 DOI: 10.1111/bph.15164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Tavares LP, Melo EM, Sousa LP, Teixeira MM. Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7). Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101601] [Reference Citation Analysis]
22 Jacqueline C, Dracz M, Boothman S, Minden JS, Gottschalk RA, Finn OJ. Identification of Cell Surface Molecules That Determine the Macrophage Activation Threshold Associated With an Early Stage of Malignant Transformation. Front Immunol 2021;12:749597. [PMID: 34712237 DOI: 10.3389/fimmu.2021.749597] [Reference Citation Analysis]